Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Pierre Beaurang currently holds 6,210 shares of Nurix Therapeutics, Inc. (NRIX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Pierre Beaurang has been a net seller of NRIX stock. They have purchased $0 and sold $1.8M worth of shares.
Pierre Beaurang's most recent insider trade was on Aug 10, 2021, when they sold 5,620 shares at $29.74 per share.
Pierre Beaurang serves as Executive at Nurix Therapeutics, Inc. (NRIX). They have executed 32 insider transactions totaling $1.8M over their tenure at the company.
Pierre Beaurang holds the position of Executive at Nurix Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 6 years and currently hold a stake valued at $0.
Pierre Beaurang has shown a selling trading pattern, with $0 in total purchases and $1.8M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Pierre Beaurang was on Feb 18, 2021, when they sold $230.3K worth of NRIX shares. This transaction involved 6,400 shares at $35.99 per share.
Pierre Beaurang currently owns 6,210 shares of Nurix Therapeutics, Inc. (NRIX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Pierre Beaurang's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Pierre Beaurang has 32 Form 4 filings on record as an insider at Nurix Therapeutics, Inc..
Set alerts for Pierre Beaurang and 40,000+ other insiders.